I’ve had to read — and respond to — enough FDA 483s and warning letters to know they’re rarely about a single misplaced document. Warning letters are the symptom; the cause is usually a broken set of controls working together. To be fair, FDA’s focus is patient safety. In practice this means they look for systemic failures you should have detected earlier under your own QMS. The typical route: inspection → 483 → warning letter FDA inspects. Inspectors document observations on Form FDA 483 (the “483”). Many observations are fixable nonconformities, but patterns matter. You submit a response (industry normal practice is to respond promptly — commonly within 15 business days — with corrective actions). If the response is inadequate, or the problem is serious, FDA escalates to a warning letter. A warning letter is public, formal, and signals that FDA is not satisfied with your corrective actions or that the issue represents a substantive violation (or both).…